Navigation Links
The GW Department of Biochemistry and Molecular Biology to host Nobel Laureate Dr. Ferid Murad
Date:9/27/2010

The George Washington University Medical Center's Department of Biochemistry & Molecular Biology welcomes the Nobel Laureate in Physiology or Medicine, Ferid Murad, M.D., Ph.D., as the inaugural speaker for The Nobel Laureate Distinguished Lecture Series. The series will showcase the achievements made within the scientific field in recent years. The inaugural lecture in this series will be co-sponsored by the GW Office of the Provost and the GW Office of the Vice President for Research.

In his lecture titled "NO Signaling: From Discovery to Drug Development," Dr. Murad will discuss his pioneering studies and breakthrough research on the mechanism of action of nitroglycerin, a drug used to reduce pain in cardiac ischemia among other uses. He will focus on the role of nitric oxide as a signaling molecule to relax smooth muscle and other new developments. Dr. Murad shared the Nobel Prize in Physiology or Medicine for this research in 1998 with Robert F. Furchgott, Ph.D., and Louis J. Ignarro, Ph.D.

Title: NO Signaling: From Discovery to Drug Development

When: Wednesday, September 29, 2010, 10:00 a.m.

Where: Funger Hall 103, 2201 G St. NW, Washington, D.C. 20037

Biography in brief

Born in Whiting, Indiana, Dr. Ferid Murad studied medicine and pharmacology simultaneously at Western Reserve University, receiving both his M.D. and Ph.D. in 1965. He was an intern and resident in internal medicine at Massachusetts General Hospital until 1967, and then worked until 1970 at the National Institutes of Health's National Heart and Lung Institute as a clinical associate and staff fellow.

He followed a series of academic, research, and administrative appointments, beginning at the University of Virginia, continuing on at Stanford University and Palo Alto Veterans Administration Medical Center, and more recently, at the University of Texas (1996-2010) where he serves as the Director of the Institute for Molecular Medicine, for the Houston School of Medicine.

Dr. Murad's work with nitric oxide began when he was in graduate school. He set out to learn how nitroglycerin, used for more than 100 years to treat angina, affected blood vessels. He found that nitroglycerin was effective because it prompted the release of nitric oxide, which relaxed smooth muscle cells. Prior to this, nitric oxide was best known as an air pollutant present in automobile exhaust fumes. The gas was known to be present in bacteria, but it was not thought to be important in higher order animals such as mammals. Based on this, Dr. Murad postulated that nitric oxide and other nitrogen-containing compounds (he coined the term nitro vasodilators to describe them) might be produced by one cell, travel through membranes, and then regulate the function other cells. At the time, this was an entirely new concept for signaling in biological systems. Nitric oxide is now known to play a key role in many biological functions including inflammation, blood flow regulation, cell growth, smooth muscle relaxation, and preserving memory.


'/>"/>

Contact: Anne Banner
mcmacb@gwumc.edu
202-994-2261
George Washington University Medical Center
Source:Eurekalert

Related biology news :

1. Jefferson Department of Surgery announces new pancreas tumor registry
2. UC Riverside rice geneticist receives high honor from US Department of Agriculture
3. New dummy design and development wins US Department of Defense award
4. Lockheed Martin Team Wins Role on Key Department of Defense Biometrics Contract Vehicle
5. Raytheon Chosen to Help Provide Department of Defense Biometrics Operations and Support Services
6. CSC Awarded Department of Defense Biometrics Contract
7. Story tips from the Departments of Energys Oak Ridge National Lab -- March 2009
8. Reforming defense department acquisition policy: UM expert
9. Story tips From the Department of Energys Oak Ridge National Laboratory -- May 2009
10. Story tips from the Department of Energys Oak Ridge National Laboratory, June 2009
11. Department of Energy supports carbon sequestration research, University of Miami receives $1.7 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona combed ... pleural mesothelioma. Their findings are the subject of a new article on the Surviving ... signposts in the blood, lung fluid or tissue of mesothelioma patients that can help ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
Breaking Biology Technology: